GlassScriptPhysician profile
Sarfraz Durrani
NPI 1770671711
$12,626.58
in general payments reported to CMS, 2019-2025
27 companies · $2,797 in 2025
The $2,797 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,680 · 2020: $1,470 · 2021: $1,401 · 2022: $726 · 2023: $1,578 · 2024: $975 · 2025: $2,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,210 · Travel and Lodging: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,209.54 |
| Travel and Lodging | $1,140.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,512.60 | 2021-2025 | Na, Micra, Affera Mapping System |
| Abbott Laboratories | $3,382.93 | 2019-2025 | Ensite, Jot Dx, Aveir |
| Boston Scientific Corporation | $1,177.17 | 2019-2025 | Watchman Access System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic Vascular, INC. | $1,048.48 | 2019-2020 | |
| Atricure, INC. | $750.02 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Pfizer INC. | $344.49 | 2019-2025 | |
| Biosense Webster, INC. | $297.22 | 2022-2025 | Carto 3, Visitag Surpoint External Processing Unit |
| Janssen Pharmaceuticals, INC | $211.55 | 2019-2023 | Xarelto |
| Zoll Respicardia, INC. | $172.25 | 2021 | |
| Sanofi-Aventis U.S. LLC | $142.56 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $81.48 | 2019-2024 | Eliquis |
| Cardiva Medical, INC. | $77.14 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $63.40 | 2024 | (Ck4) Mcot |
| Irhythm Technologies, INC. | $50.32 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.02 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $37.59 | 2023 | Optimizer |
| Angiodynamics, INC. | $30.38 | 2025 | Alphavac |
| Bardy Diagnostics, INC. | $28.17 | 2022 | |
| Baxter Healthcare | $25.71 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $25.56 | 2024 | Wegovy |
| Ekos Corporation | $19.41 | 2019 | |
| Kestra Medical Technology Services, INC. | $18.75 | 2023 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.39 | 2019 | |
| Cvrx, INC. | $18.08 | 2024 | Barostim Neo System |
| Baylis Medical Company INC | $18.02 | 2021 | |
| Merck Sharp & Dohme LLC | $15.87 | 2022 | |
| Terumo Medical Corporation | $15.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarfraz Durrani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.